8-K
filed March 9, 2026, 7:59 PM ET
ticker LGVN
CIK 0001721484
leadership
confidence high
sentiment negative
materiality 0.40
Longeveron director Richard Kender resigns; audit committee loses financial expert
Longeveron Inc.
- Richard Kender resigned from Board and Audit Committee effective March 3, 2026, due to becoming Executive Chairman and Interim CEO of Seres Therapeutics.
- Board appointed Dr. Roger Hajjar to Audit Committee on March 4, but no member currently qualifies as audit committee financial expert.
- Company plans to appoint or submit for election a qualified director by next annual meeting or within 180-day cure period.
- Kender's resignation not due to any disagreement with the Company's operations, policies, or management.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001213900-26-024839
- form_type
- 8-K
- ticker
- LGVN
- cik
- 0001721484
- company_name
- Longeveron Inc.
- filed_at
- 2026-03-09T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:36.001582+00:00
- generated_at
- 2026-05-15T17:59:50.163918+00:00
- sec_items
- ["3.01", "5.02"]
- event_type
- leadership
- sentiment
- negative
- materiality_score
- 0.4
- calibrated_materiality_score
- 0.4
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001213900-26-024839
- json_url
- https://secwatch.observer/filing/0001213900-26-024839.json
- markdown_url
- https://secwatch.observer/filing/0001213900-26-024839.md
- text_url
- https://secwatch.observer/filing/0001213900-26-024839.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1721484/000121390026024839/0001213900-26-024839-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1721484/000121390026024839/ea0280382-8k_longeveron.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
INV
Innventure appoints John Hewitt to board, nominates Catriona Fallon after director resignation
Innventure, Inc.
April 30, 2026, 7:59 PM ET
leadership
Items 3.01, 5.02, 8.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01, 5.02
same event type: leadership
This filing
March 4, 2026 Longeveron
Inc. (the “Company”) notified Nasdaq that, as a result of the resignation of Mr. Richard Kender as a member of the Board of
Directors (the “Board”) of the Company and as chairman of the Audit Committee and the audit committee financial expert, as
described below, the Company temporarily was no longer in compliance with Nasdaq Listing Rule 5605(c)(2)(A), which requires that the audit
committee of a listed company be composed of at least three independent directors and that at least one member qualifies as an audit committee
financial expert. On March 4, 2026, the
Compan
Comparable filing
April 29, 2026. On April 29, 2026, the Company informed The Nasdaq Stock Market LLC (“Nasdaq”) that, as a result of Mr. Hennessy’s resignation from the Board and the Audit Committee, the Company was rendered noncompliant
Filing page
SEC filing
EMAT
Evolution Metals regains Nasdaq compliance after late 10-Q filing; notice resolved
Evolution Metals & Technologies Corp.
May 26, 2026, 5:28 PM ET
other_material
Items 3.01, 7.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01
similar materiality
This filing
March 4, 2026 Longeveron
Inc. (the “Company”) notified Nasdaq that, as a result of the resignation of Mr. Richard Kender as a member of the Board of
Directors (the “Board”) of the Company and as chairman of the Audit Committee and the audit committee financial expert, as
described below, the Company temporarily was no longer in compliance with Nasdaq Listing Rule 5605(c)(2)(A), which requires that the audit
committee of a listed company be composed of at least three independent directors and that at least one member qualifies as an audit committee
financial expert. On March 4, 2026, the
Compan
Comparable filing
May 21, 2026, Evolution Metals & Technologies
Corp. (the “Company”) received a notice (the “Notice”) from the Nasdaq Listing Qualifications Department of The
Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that
Filing page
SEC filing
LASE
Laser Photonics receives Nasdaq delisting notice for late Q1 2026 10-Q
Laser Photonics Corp
May 22, 2026, 5:27 PM ET
regulatory
Items 3.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01
similar materiality
This filing
March 4, 2026 Longeveron
Inc. (the “Company”) notified Nasdaq that, as a result of the resignation of Mr. Richard Kender as a member of the Board of
Directors (the “Board”) of the Company and as chairman of the Audit Committee and the audit committee financial expert, as
described below, the Company temporarily was no longer in compliance with Nasdaq Listing Rule 5605(c)(2)(A), which requires that the audit
committee of a listed company be composed of at least three independent directors and that at least one member qualifies as an audit committee
financial expert. On March 4, 2026, the
Compan
Comparable filing
received a notice from Nasdaq Listing Qualifications
department of the Nasdaq Stock Market LLC (“Nasdaq”) stating that since it had not received the Company’s Form 10-Q
for the period ended March 31, 2026, the Company does not comply with Nasdaq’s Listing Rules for continued listing. Nasdaq stated
that the Company has 60 days to submit a plan to regain compliance with respect to this delinquent report. Nasdaq can grant an exception
to allow the Company to regain compliance up to a maximum of 180 calendar days from the due date of the Initial Delinquent Filing, or
November 16, 2026. A
copy of t
Filing page
SEC filing
INV
Innventure regains Nasdaq compliance after appointing Bruce Brown to Audit Committee
Innventure, Inc.
May 19, 2026, 5:45 PM ET
regulatory
Items 3.01
same fact type: exchange_compliance_notice
same SEC item: 3.01
similar materiality
This filing
March 4, 2026 Longeveron
Inc. (the “Company”) notified Nasdaq that, as a result of the resignation of Mr. Richard Kender as a member of the Board of
Directors (the “Board”) of the Company and as chairman of the Audit Committee and the audit committee financial expert, as
described below, the Company temporarily was no longer in compliance with Nasdaq Listing Rule 5605(c)(2)(A), which requires that the audit
committee of a listed company be composed of at least three independent directors and that at least one member qualifies as an audit committee
financial expert. On March 4, 2026, the
Compan
Comparable filing
April 30, 2026, following the resignation of Daniel Hennessy from the Company’s Board of Directors (the “Board”) and Audit Committee effective April 29, 2026, the Company notified The Nasdaq Stock Market LLC (“Nasdaq”) t
Filing page
SEC filing
MYPS
PLAYSTUDIOS receives Nasdaq Capital Market transfer; second compliance period to Nov 2, 2026
PLAYSTUDIOS, Inc.
May 5, 2026, 7:59 PM ET
regulatory
Items 3.01
same fact type: exchange_compliance_notice
same SEC item: 3.01
similar materiality
This filing
March 4, 2026 Longeveron
Inc. (the “Company”) notified Nasdaq that, as a result of the resignation of Mr. Richard Kender as a member of the Board of
Directors (the “Board”) of the Company and as chairman of the Audit Committee and the audit committee financial expert, as
described below, the Company temporarily was no longer in compliance with Nasdaq Listing Rule 5605(c)(2)(A), which requires that the audit
committee of a listed company be composed of at least three independent directors and that at least one member qualifies as an audit committee
financial expert. On March 4, 2026, the
Compan
Comparable filing
May 5, 2026, Nasdaq staff approved the Company’s application to transfer its listing to the Nasdaq Capital Market. The transfer will become effective at the opening of business on May 6, 2026 (the “Transfer Date”) and wi
Filing page
SEC filing
GREE
Greenidge receives Nasdaq notice for audit committee non-compliance after director resignation
Greenidge Generation Holdings Inc.
May 1, 2026, 7:59 PM ET
regulatory
Items 3.01
same fact type: exchange_compliance_notice
same SEC item: 3.01
similar materiality
This filing
March 4, 2026 Longeveron
Inc. (the “Company”) notified Nasdaq that, as a result of the resignation of Mr. Richard Kender as a member of the Board of
Directors (the “Board”) of the Company and as chairman of the Audit Committee and the audit committee financial expert, as
described below, the Company temporarily was no longer in compliance with Nasdaq Listing Rule 5605(c)(2)(A), which requires that the audit
committee of a listed company be composed of at least three independent directors and that at least one member qualifies as an audit committee
financial expert. On March 4, 2026, the
Compan
Comparable filing
April 29, 2026, the Company received a notice from Nasdaq (the “Notice”) confirming the Company’s non-compliance with Nasdaq Listing Rule 5605(c)(2)(A) as a result of Mr. Fearn’s resignation from the Audit Committee. As
Filing page
SEC filing
ARAI
Arrive AI regains compliance with Nasdaq MVPHS rule; delisting notice closed
Arrive AI Inc.
April 28, 2026, 7:59 PM ET
regulatory
Items 3.01
same fact type: exchange_compliance_notice
same SEC item: 3.01
similar materiality
This filing
March 4, 2026 Longeveron
Inc. (the “Company”) notified Nasdaq that, as a result of the resignation of Mr. Richard Kender as a member of the Board of
Directors (the “Board”) of the Company and as chairman of the Audit Committee and the audit committee financial expert, as
described below, the Company temporarily was no longer in compliance with Nasdaq Listing Rule 5605(c)(2)(A), which requires that the audit
committee of a listed company be composed of at least three independent directors and that at least one member qualifies as an audit committee
financial expert. On March 4, 2026, the
Compan
Comparable filing
March 31, 2026, Arrive AI Inc. (the “ Company ”) received a letter from The Nasdaq Listing Qualifications Department
(the “ Staff ”) indicating that the Company’s common stock had failed to maintain a minimum market valu
Filing page
SEC filing
TPST
Tempest Therapeutics warned by Nasdaq for low equity and board independence; two directors resign
Tempest Therapeutics, Inc.
May 22, 2026, 5:28 PM ET
regulatory
Items 3.01, 5.02
same fact type: exchange_compliance_notice
same SEC item: 3.01, 5.02
This filing
March 4, 2026 Longeveron
Inc. (the “Company”) notified Nasdaq that, as a result of the resignation of Mr. Richard Kender as a member of the Board of
Directors (the “Board”) of the Company and as chairman of the Audit Committee and the audit committee financial expert, as
described below, the Company temporarily was no longer in compliance with Nasdaq Listing Rule 5605(c)(2)(A), which requires that the audit
committee of a listed company be composed of at least three independent directors and that at least one member qualifies as an audit committee
financial expert. On March 4, 2026, the
Compan
Comparable filing
May 22, 2026, Tempest Therapeutics, Inc. (the “Company”) notified the Nasdaq Stock Market LLC (“Nasdaq”) that the Company will not be in compliance with the majority independent director requirement under Nasdaq Listing
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.